New drug aims to protect Kids' immune systems during chemo
Symptom relief
Recruiting now
This study tests a drug called eflapegrastim in 40 children with solid tumors or lymphoma who are receiving chemotherapy. The goal is to see if it safely helps their white blood cell counts recover faster, reducing the risk of serious infections. Participants will be monitored fo…
Phase: PHASE2 • Sponsor: Spectrum Pharmaceuticals, Inc • Aim: Symptom relief
Last updated May 17, 2026 09:21 UTC